Question reference: S6W-24789
- Asked by: Alex Cole-Hamilton, MSP for Edinburgh Western, Scottish Liberal Democrats
- Date lodged: 24 January 2024
-
Current status: Answered by Jenni Minto on 5 February 2024
Question
To ask the Scottish Government whether it is aware of any issues with the supply of Creon, which is a pancreatic enzyme replacement therapy required to aid the uptake of nutrients from food for people with cystic fibrosis, and what action is being taken to resolve any such supply issues.
Answer
The Scottish Government is aware that there have been supply issues with Pancreatin, also known as Creon, with one or more strengths over a number of years. Other brands of prescription pancreatic enzymes are also available including Nutrizym® and Pancrex®. Patients should discuss alternative options with their GP or specialist.
Officials from the four UK Administrations work together to mitigate and manage responses to medicine shortages. The Chief Pharmaceutical Officer for Scotland is a member of the UK-wide Medicines Shortage Response Group (MSRG), set up to identify and co-ordinate responses to medicines shortages across the UK and provide advice to clinicians on alternative therapeutic options.
The NHS in Scotland has robust processes in place to manage supply issues when they do arise.